CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.
about
CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CD109 released from human bone ...... ss of squamous cell carcinoma.
@en
CD109 released from human bone ...... ss of squamous cell carcinoma.
@nl
type
label
CD109 released from human bone ...... ss of squamous cell carcinoma.
@en
CD109 released from human bone ...... ss of squamous cell carcinoma.
@nl
prefLabel
CD109 released from human bone ...... ss of squamous cell carcinoma.
@en
CD109 released from human bone ...... ss of squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
CD109 released from human bone ...... ss of squamous cell carcinoma.
@en
P2093
Anie Philip
Renzo Cecere
Shufeng Zhou
P2860
P304
95632-95647
P356
10.18632/ONCOTARGET.21067
P407
P577
2017-09-16T00:00:00Z